Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Less Is More: FDAMA Implementation Veteran Will Guide User Fee Program

This article was originally published in The Gray Sheet

Executive Summary

Office of Device Evaluation IDE/HDE Programs Director Joanne Less will help supervise implementation of the Center for Devices & Radiological Health's user fee program

You may also be interested in...



FDA Veteran Schultz Ascends To CDRH Director Position: Who Will Lead ODE?

CDRH's new director, Daniel Schultz, MD, says he would be open to hiring an Office of Device Evaluation chief who lacks a medical degree

FDA Veteran Schultz Ascends To CDRH Director Position: Who Will Lead ODE?

CDRH's new director, Daniel Schultz, MD, says he would be open to hiring an Office of Device Evaluation chief who lacks a medical degree

CDRH Senior Staff Will Meet Every Two Weeks, Evaluate User Fee Resources

An FDA steering committee will oversee the progress of the user fee program among its centers as the agency implements the Medical Device User Fee & Modernization Act

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT017526

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel